Clinical trials
Phase 3 Liver Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 7 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 5 |
| Mirum Pharmaceuticals, Inc. | 3 |
| 89bio, Inc. | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| University of Colorado, Denver | 2 |
| Abbott | 1 |
| Aga Khan University | 1 |
| Cardiox Corporation | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 46 |
| Digestive System Diseases | 13 |
| Fibrosis | 12 |
| Hepatitis C | 12 |
| Hepatitis | 8 |
| Hepatitis C, Chronic | 8 |
| Virus Diseases | 8 |
| Hepatitis, Viral, Human | 7 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Hepatitis B | 5 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.